HLA-mismatched GPBMC infusion

Graft-derived peripheral blood mononuclear cell infusion

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLA-mismatched GPBMC infusion, covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia [Phase 1]